MoneyWorks4Me

The Sales for the quarter ended September 2024 of Rs. 1073.54 millions rose by 30.94% from Rs. 819.85 millions.A slim rise of 8.56% was recorded in the Net profit for the quarter ended September 2024 to Rs. 42.74  millions  From Rs. 39.37 millions.OP of the company witnessed a marginal growth to 139.52 millions from 96.08 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 1073.54 819.85 30.94 1861.65 1440.30 29.25 3490.72 2764.98 26.25
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 139.52 96.08 45.21 244.31 172.15 41.92 388.98 296.00 31.41
Interest 53.12 29.00 83.17 92.24 55.12 67.34 136.50 92.82 47.06
PBDT 86.40 67.08 28.80 152.07 117.03 29.94 252.48 203.18 24.26
Depreciation 10.63 9.39 13.21 21.10 18.54 13.81 37.96 28.09 35.14
PBT 75.77 57.69 31.34 130.97 98.49 32.98 214.52 175.09 22.52
TAX 33.03 18.32 80.29 46.92 35.10 33.68 58.28 67.02 -13.04
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 42.74 39.37 8.56 84.05 63.39 32.59 156.24 108.07 44.57
Equity 47.22 46.84 0.81 47.22 46.84 0.81 46.99 45.32 3.68
PBIDTM(%) 13.00 11.72 10.90 13.12 11.95 9.80 11.14 10.71 4.09
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..